Skip to main content

Plaintiffs Not in Favor of Splitting Roundup MDL Trial

Plaintiffs Not in Favor of Splitting Roundup MDL Trial

Plaintiffs Not in Favor of Splitting Roundup MDL Trial

Introduction

Plaintiffs involved in Monsanto's weed killer Roundup litigation opposed the federal judge's proposal to bifurcate upcoming bellwether trials into separate general causation and specification trials and called the decision as "unorthodox" and "ill-advised."

The agrochemical company would prefer the federal court trials to be conducted in two separate phases; one involving medical causation; the second phase to address liability issues if the plaintiffs prevail in the first phase. The company asserted the issue of causation and compensatory damages are separate from the negligent conduct claims filed against them and bifurcation suggested by the judge would unnecessarily delay the case resolution. Plaintiff attorneys call the bifurcation decision as "unheard of" in the modern multidistrict litigation (MDL) which is under U.S. District Court Judge Vince Chhabria.  

More than 600 lawsuits are pending in the MDL alleging exposure to glyphosate-based herbicide manufactured by Monsanto developed deadly cancer in several individuals. Judge Chhabria indicated he would rule on this issue before Christmas. The next bellwether trial date is set for February 25, 2019, involving claims filed by a California resident Edwin Hardeman.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.